JP2007269667A - Antibacterial agent - Google Patents
Antibacterial agent Download PDFInfo
- Publication number
- JP2007269667A JP2007269667A JP2006096017A JP2006096017A JP2007269667A JP 2007269667 A JP2007269667 A JP 2007269667A JP 2006096017 A JP2006096017 A JP 2006096017A JP 2006096017 A JP2006096017 A JP 2006096017A JP 2007269667 A JP2007269667 A JP 2007269667A
- Authority
- JP
- Japan
- Prior art keywords
- sasanqua
- extract
- antibacterial
- antibacterial agent
- cosmetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003242 anti bacterial agent Substances 0.000 title claims abstract description 13
- 239000000284 extract Substances 0.000 claims abstract description 33
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 23
- 238000002360 preparation method Methods 0.000 claims abstract description 5
- 239000000203 mixture Substances 0.000 claims description 6
- 230000000699 topical effect Effects 0.000 claims 1
- 239000002537 cosmetic Substances 0.000 abstract description 22
- 206010040880 Skin irritation Diseases 0.000 abstract description 9
- 230000036556 skin irritation Effects 0.000 abstract description 9
- 231100000475 skin irritation Toxicity 0.000 abstract description 9
- 239000002253 acid Substances 0.000 abstract description 6
- 150000002148 esters Chemical class 0.000 abstract description 5
- 239000005445 natural material Substances 0.000 abstract description 2
- 239000003755 preservative agent Substances 0.000 abstract description 2
- 230000002335 preservative effect Effects 0.000 abstract description 2
- 240000006833 Camellia sasanqua Species 0.000 abstract 2
- 235000002537 Camellia sasanqua Nutrition 0.000 abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 23
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
- -1 cationic amino acid derivatives Chemical class 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 239000003963 antioxidant agent Substances 0.000 description 7
- 235000006708 antioxidants Nutrition 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 230000003078 antioxidant effect Effects 0.000 description 6
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 6
- 230000000903 blocking effect Effects 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 239000006210 lotion Substances 0.000 description 5
- 239000002304 perfume Substances 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- 239000000419 plant extract Substances 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 3
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 229930007845 β-thujaplicin Natural products 0.000 description 3
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 2
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 229940036350 bisabolol Drugs 0.000 description 2
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 125000005456 glyceride group Chemical group 0.000 description 2
- 150000002334 glycols Chemical class 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- KNUPSOXBESCJLY-UHFFFAOYSA-N 2-methoxy-1-phenylhexan-1-one Chemical compound CCCCC(OC)C(=O)C1=CC=CC=C1 KNUPSOXBESCJLY-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940050390 benzoate Drugs 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000008278 cosmetic cream Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229940071120 dehydroacetate Drugs 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000003063 flame retardant Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 229940087068 glyceryl caprylate Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical class O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229940107702 grapefruit seed extract Drugs 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 150000002814 niacins Chemical class 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
Abstract
Description
本発明は、天然素材であり優れた抗菌性を有するザザンカの葉の抽出物を配合する抗菌剤に関する。 The present invention relates to an antibacterial agent containing a Zazanka leaf extract which is a natural material and has excellent antibacterial properties.
化粧料には、外部から混入してくる微生物の増殖を抑制し、経時とともに死滅させ製品の劣化を防止する目的で抗菌剤が使用される。代表的なものとして、パラオキシ安息香酸エステルが汎用されている。パラオキシ安息香酸エステルは、食品にも汎用されているが、過去アレルギーが認められた経緯があり、皮膚刺激性に問題が指摘されており、化粧料への配合に関しては配合の上限が規定されている。その他、安息香酸塩、サリチル酸塩やデヒドロ酢酸塩もよく使用されるがパラオキシ安息香酸エステルと同様に皮膚刺激の問題が指摘されている。 In cosmetics, antibacterial agents are used for the purpose of suppressing the growth of microorganisms mixed in from the outside and killing them with time to prevent the deterioration of the product. As a representative one, paraoxybenzoic acid esters are widely used. Although paraoxybenzoic acid esters are widely used in foods, there is a history of allergies in the past, and problems with skin irritation have been pointed out. Yes. In addition, benzoate, salicylate, and dehydroacetate are often used, but skin irritation problems have been pointed out as in the case of paraoxybenzoate.
近年、フェノキシエタノールによって抗菌性をもたせる動きがあるが、皮膚刺激の問題は回避できているとは言えない。また、天然系の抗菌性を有する物質としては、ヒノキチオール、モノカプリル酸グリセリド、カチオン系アミノ酸誘導体、ビサボロール、グリコール類、及び植物抽出液としてのローズマリー抽出液やグレープフルーツ種子抽出液等が知られており、それらを併用して微生物の増殖を抑えることも試されている。しかしながら、ヒノキチオールは、鉄イオンの存在下で褐変を起こすことが知られている。モノカプリル酸グリセリルは、水存在下でエステル結合が加水分解作用により遊離したカプリル酸が発生し、その臭いが好ましくない。
本発明の課題は、皮膚刺激等の安全面での問題のない新たな抗菌剤の提供である。 An object of the present invention is to provide a new antibacterial agent having no safety problems such as skin irritation.
本発明者は、係る情況に鑑み鋭意研究を重ねた結果、サザンカの葉の抽出物が抗菌活性を有することを見出し、本発明の完成に至った。即ち、本発明は、サザンカの葉の抽出物を特徴とする抗菌剤である。 As a result of intensive studies in view of the circumstances, the present inventor has found that the extract of the leaves of sasanqua has antibacterial activity, and has completed the present invention. That is, the present invention is an antibacterial agent characterized by an extract of sasanqua leaves.
本発明によれば、サザンカ葉抽出物を含むことを特徴とする抗菌剤を配合することにより、パラオキシ安息香酸エステル等の皮膚刺激を有する防腐剤を使用せずして十分な抗菌作用を有する安全性に優れた化粧料の提供が可能となる。 According to the present invention, by adding an antibacterial agent characterized by containing a sasanqua leaf extract, a safety having a sufficient antibacterial action without using a preservative having skin irritation such as paraoxybenzoate ester It is possible to provide cosmetics with excellent properties.
本発明のサザンカの葉の抽出物は、単独でも十分な抗菌性を示すが、少量のエタノール、フェノキシエタノール、ヒノキチオール、モノカプリル酸グリセリド、カチオン系アミノ酸誘導体、ビサボロールや1,2−ペンタンジオール、1,2−ヘキサンジオール等の抗菌剤を併用することによって、相乗的に抗菌作用や抗菌範囲が向上する。 The extract of the sasanqua leaves of the present invention exhibits sufficient antibacterial properties by itself, but a small amount of ethanol, phenoxyethanol, hinokitiol, monocaprylic acid glycerides, cationic amino acid derivatives, bisabolol and 1,2-pentanediol, 1, By using an antibacterial agent such as 2-hexanediol in combination, the antibacterial action and the antibacterial range are synergistically improved.
本発明の抗菌剤には、上記した必須成分の他に通常の化粧品や医薬品、医薬部外品等に用いられる他の成分、例えば、ビタミンB2類、ビタミンB6類、ビタミンC類、ビタミンD類、ニコチン酸類、ビタミンE類、ビタミンP、ビオチン等のビタミン類、アミノ酸及びアミノ酸誘導体、ホホバ油、スクワラン等の油分、グリセリン、ソルビトール、1,3−ブチレングリコール等のグリコール類、コラーゲン、ヒアルロン酸等の高分子保湿剤、酸化防止剤、界面活性剤、グリチルリチン酸誘導体等の消炎剤、各種植物抽出物、カルボキシビニルポリマー等の増粘剤、香料、水、アルコール、色剤、ポリエチレン等の樹脂粉末等を必要に応じて適宜配合することができる。 In addition to the above-mentioned essential components, the antibacterial agent of the present invention includes other components used in normal cosmetics, pharmaceuticals, quasi drugs, etc., for example, vitamin B2, vitamin B6, vitamin C, vitamin D Vitamins such as nicotinic acids, vitamin E, vitamin P, biotin, amino acids and amino acid derivatives, oils such as jojoba oil and squalane, glycols such as glycerin, sorbitol, and 1,3-butylene glycol, collagen, hyaluronic acid, etc. Polymer moisturizers, antioxidants, surfactants, flame retardants such as glycyrrhizic acid derivatives, various plant extracts, thickeners such as carboxyvinyl polymer, flavoring, water, alcohol, colorants, resin powders such as polyethylene Etc. can be appropriately blended as necessary.
本発明に用いることができるサザンカの葉の抽出物の各種化粧料に対する配合量は、化粧料の実施態様、化粧料の使用形態などに応じて変動させることが可能で特に限定されない。原則的には、化粧料中に有効量存在すれば良いが、一般的な配合量は、化粧料組成物中0.001〜5質量%であり、好ましくは0.01〜3.0質量%、更に好ましくは0.1〜1.0質量%であるが、化粧料の剤型や処方内容により適正量は特に限定することはできないための目安である。 The blending amount of the extract of the leaf of sasanqua that can be used in the present invention with respect to various cosmetics can be varied according to the embodiment of the cosmetics, the usage form of the cosmetics, etc., and is not particularly limited. In principle, an effective amount may be present in the cosmetic, but the general blending amount is 0.001 to 5% by mass, preferably 0.01 to 3.0% by mass in the cosmetic composition. More preferably, it is 0.1 to 1.0% by mass, but this is an indication that the appropriate amount cannot be particularly limited depending on the dosage form of the cosmetic and the content of the formulation.
本発明に係る化粧料への適用範囲は、剤型等による制限はなく、全ての化粧料に適用が可能である。 The range of application to the cosmetic according to the present invention is not limited by the dosage form, and can be applied to all cosmetics.
例えば、本発明にかかる有効成分をクリーム、乳液、化粧水、パック剤、洗顔料などの各種基礎化粧料、ファンデーション、口紅、ほほ紅、白粉などの各種メーキャップ料、洗髪料、養毛剤、シャンプー、リンスなどの各種頭髪用化粧料、石鹸、美爪料、オーデコロン等その他化粧料に対して適用可能である。また、前記各種化粧料の実施態様は、溶液、エマルジョン、軟膏、ゾル、ゲル、パウダー、スプレー等の各種態様においても適用可能である。 For example, the active ingredients according to the present invention include various basic cosmetics such as creams, milky lotions, lotions, packs, facial cleansers, foundations, lipsticks, cheeks, white powders, makeup products, hair shampoos, hair nourishing agents, shampoos, rinses. It is applicable to other cosmetics such as various hair cosmetics such as soap, beauty nail, and cologne. The embodiments of the various cosmetics can also be applied to various embodiments such as solutions, emulsions, ointments, sols, gels, powders, and sprays.
以下、本発明を実施例により更に具体的に説明するが、本発明は実施例に限定されることはない。 EXAMPLES Hereinafter, although an Example demonstrates this invention further more concretely, this invention is not limited to an Example.
〔サザンカの葉の抽出物の製造〕
まず、本発明にかかる皮膚外用剤において特徴的なサザンカの葉の抽出物の製造例について説明する。
[Manufacture of sasanqua leaf extract]
First, the manufacture example of the extract of the leaf of a sasanqua characteristic in the skin external preparation concerning this invention is demonstrated.
〔実施例1から得られるエキスの作成〕
原材料として、サザンカの葉を20g使用した。前記原材料20gにエタノール100mLを加え、90℃で6時間加熱抽出した後上澄みを遠心分離し、比較的大きい浮遊物を除去したあと、メッシュ径0.22μmのろ紙を用いてろ過する。ロータリーエバポレーターにて減圧濃縮し、サザンカ葉エキス約0.5gを得た。
[Preparation of extract obtained from Example 1]
As raw material, 20 g of sasanqua leaves were used. 100 mL of ethanol is added to 20 g of the raw material, and the mixture is heated and extracted at 90 ° C. for 6 hours. The supernatant is centrifuged to remove relatively large suspended matters, and then filtered using a filter paper having a mesh diameter of 0.22 μm. Concentration under reduced pressure using a rotary evaporator gave about 0.5 g of sasanqua leaf extract.
〔細菌に対する抗菌作用〕
E.coliを用いて、ペーパーディスク法(直径6mmのペーパーディスク使用)にて植物抽出物の抗菌作用を調べた。試料は、上記抽出物を1w/v%となるようにジメチルスルホキシド(DMSO)に溶解して用いた。培養は、Soybean-Casein Digest
Broth(SCDLP)培地を用いて、嫌気下37℃3日間行った。その結果を表1に示す。表1から分かるように、サザンカ抽出物から得られた抽出物には1%の濃度で抗菌・殺菌作用が確認された。なお、抗菌作用の評価は以下の基準で行った。
++;阻止円の直径20mm以上
+ ;阻止円の直径12mm以上
± ;阻止円の直径 8mm以下
[Antimicrobial activity against bacteria]
E. The antibacterial action of the plant extract was examined by the paper disk method (using a paper disk having a diameter of 6 mm) using E. coli. The sample was used by dissolving the above extract in dimethyl sulfoxide (DMSO) so as to be 1 w / v%. Culture is Soybean-Casein Digest
Broth (SCDLP) medium was used under anaerobic conditions at 37 ° C. for 3 days. The results are shown in Table 1. As can be seen from Table 1, the antibacterial and bactericidal action was confirmed in the extract obtained from the sasanqua extract at a concentration of 1%. The antibacterial action was evaluated according to the following criteria.
++: Blocking circle diameter 20 mm or more +; Blocking circle diameter 12 mm or more ±; Blocking circle diameter 8 mm or less
〔真菌に対する抗菌作用〕
A.nigerを用いて、ペーパーディスク法(直径6mmのペーパーディスク使用)にて植物抽出物の抗菌作用を調べた。試料は、上記抽出物を1w/v%となるようにジメチルスルホキシド(DMSO)に溶解して用いた。培養は、Glucose Peptone Agar
with Lecithin & Polysorbate 80(GDLP)培地を用いて、嫌気下37℃3日間行った。その結果を表2に示す。表2から分かるように、サザンカ抽出物から得られた抽出物には1%の濃度で抗菌・殺菌作用が確認された。なお、抗菌作用の評価は以下の基準で行った。
++;阻止円の直径20mm以上
+ ;阻止円の直径12mm以上
± ;阻止円の直径 8mm以下
[Antimicrobial activity against fungi]
A. Using niger, the antibacterial action of the plant extract was examined by the paper disc method (using a paper disc having a diameter of 6 mm). The sample was used by dissolving the above extract in dimethyl sulfoxide (DMSO) so as to be 1 w / v%. Culture is Glucose Peptone Agar
With Lecithin & Polysorbate 80 (GDLP) medium, it was performed under anaerobic conditions at 37 ° C. for 3 days. The results are shown in Table 2. As can be seen from Table 2, antibacterial and bactericidal action was confirmed in the extract obtained from the sasanqua extract at a concentration of 1%. The antibacterial action was evaluated according to the following criteria.
++: Blocking circle diameter 20 mm or more +; Blocking circle diameter 12 mm or more ±; Blocking circle diameter 8 mm or less
〔実験例2:抗菌力(チャレンジテスト)の確認〕
サザンカの葉の抽出物において、法定5菌種(S.aureus、E.coli.、Ps.aerginosa、C.arbicans、A.niger)に対する抗菌性の確認試験を行った。試料は、サザンカ葉エキスを含有する化粧水、サザンカ葉エキスの溶剤としてエタノールを含有する化粧水を調製し試験に供した。
[Experiment 2: Confirmation of antibacterial activity (challenge test)]
The extract of sasanqua leaves was subjected to antibacterial confirmation tests against five legal species (S. aureus, E. coli, Ps. Aerginosa, C. arbicans, A. niger). As samples, a lotion containing a sasanqua leaf extract and a lotion containing ethanol as a solvent for the sasanqua leaf extract were prepared and subjected to the test.
〔判定基準〕
判定基準については、以下の5段階にて評価した。
◎:顕著な菌数の減少が見られた。
○:菌数の減少が見られた。
△:穏やかな菌数の減少が見られた。
▲:菌数の減少及び増加がみられなかった
×:菌数の増加が見られた。
[Criteria]
Evaluation criteria were evaluated in the following five stages.
(Double-circle): The remarkable reduction | decrease in the number of bacteria was seen.
○: A decrease in the number of bacteria was observed.
Δ: A moderate decrease in the number of bacteria was observed.
▲: Decrease or increase in the number of bacteria was not observed ×: Increase in the number of bacteria was observed.
サザンカ葉抽出物の溶剤としてエタノールを含む抗菌作用について、「真菌」に対する効果を表3に示す。 Table 3 shows the effect on “fungi” for the antibacterial action including ethanol as a solvent for the sasanqua leaf extract.
「細菌」に対する効果を表4に示す。 Table 4 shows the effect on “bacteria”.
表3、4の結果から、パラオキシ安息香酸エステルを使用せずとも、化粧料の品質を維持する為に十分な抗菌作用を示すことを確認した。 From the results of Tables 3 and 4, it was confirmed that sufficient antibacterial action was exhibited to maintain the quality of cosmetics without using paraoxybenzoate.
次に本発明に係るサザンカ葉抽出物とエタノールを併用した具体的な化粧料について説明する。 Next, the specific cosmetics using the sasanqua leaf extract and ethanol according to the present invention will be described.
以下に本発明の処方例を挙げる。
<処方例1>化粧水
(質量%)
サザンカの葉の抽出物 5.0
エタノール 5.0
グリセリン 5.0
ポリオキシエチレンソルビタンモノラウレート(20E.0) 1.5
酸化防止剤 適 量
精製水 残 部
The formulation example of this invention is given to the following.
<Prescription Example 1> Lotion (mass%)
Sasanqua leaf extract 5.0
Ethanol 5.0
Glycerin 5.0
Polyoxyethylene sorbitan monolaurate (20E.0) 1.5
Antioxidant Appropriate amount of purified water balance
<処方例2>化粧用クリーム
(質量%)
サザンカの葉の抽出物 0.001
エタノール 5.0
ミツロウ 2.0
ステアリルアルコール 5.0
ステアリン酸 8.0
スクワラン 10.0
自己乳化型グリセリルモノステアレート 3.0
ポリオキシエチレンセチルエーテル(20E.0) 1.0
1,3−ブチレングリコール 5.0
水酸化カリウム 0.3
香料 適量
酸化防止剤 適量
精製水 残部
<Formulation example 2> Cosmetic cream (mass%)
Sasanqua leaf extract 0.001
Ethanol 5.0
Beeswax 2.0
Stearyl alcohol 5.0
Stearic acid 8.0
Squalane 10.0
Self-emulsifying glyceryl monostearate 3.0
Polyoxyethylene cetyl ether (20E.0) 1.0
1,3-butylene glycol 5.0
Potassium hydroxide 0.3
Perfume Appropriate amount Antioxidant Appropriate amount Purified water The rest
<処方例3>乳液
(質量%)
サザンカの葉の抽出物 1.0
エタノール 5.0
スクワラン 8.0
ワセリン 2.0
ミツロウ 0.5
ソルビタンセスキオレエート 0.8
ポリオキシエチレンオレイルエーテル(20E.0) 1.2
カルボキシビニルポリマー 0.2
水酸化カリウム 0.1
1.3−ブチレングリコール 7.0
香料 適量
酸化防止剤 適量
精製水 残部
<Prescription Example 3> Emulsion (mass%)
Sasanqua leaf extract 1.0
Ethanol 5.0
Squalane 8.0
Vaseline 2.0
Beeslow 0.5
Sorbitan sesquioleate 0.8
Polyoxyethylene oleyl ether (20E.0) 1.2
Carboxyvinyl polymer 0.2
Potassium hydroxide 0.1
1.3-Butylene glycol 7.0
Perfume Appropriate amount Antioxidant Appropriate amount Purified water The rest
<処方例4>パック剤
(質量%)
サザンカの葉の抽出物 0.1
エタノール 5.0
酢酸ビニル樹脂エマルジョン 15.0
ポリビニルアルコール 10.0
ホホバ油 3.0
グリセリン 5.0
酸化チタン 8.0
カオリン 7.0
香料 適量
酸化防止剤 適量
精製水 残部
<Prescription Example 4> Packing agent (mass%)
Sasanqua leaf extract 0.1
Ethanol 5.0
Vinyl acetate resin emulsion 15.0
Polyvinyl alcohol 10.0
Jojoba oil 3.0
Glycerin 5.0
Titanium oxide 8.0
Kaolin 7.0
Perfume Appropriate amount Antioxidant Appropriate amount Purified water The rest
<処方例5>軟膏
(質量%)
サザンカの葉の抽出物 3.0
エタノール 5.0
酢酸トコフェロール 0.5
パラジメチルアミノ安息香酸オクチル 4.0
ブチルメトキシベンゾイルメタン 4.0
ステアリルアルコール 18.0
モクロウ 20.0
グリセリンモノステアリン酸エステル 0.3
ワセリン 33.0
香料 適量
酸化防止剤 適量
精製水 残部
<Prescription Example 5> Ointment (mass%)
Sasanqua leaf extract 3.0
Ethanol 5.0
Tocopherol acetate 0.5
Octyl paradimethylaminobenzoate 4.0
Butylmethoxybenzoylmethane 4.0
Stearyl alcohol 18.0
Owl 20.0
Glycerin monostearate 0.3
Vaseline 33.0
Perfume Appropriate amount Antioxidant Appropriate amount Purified water The rest
<処方例6>アイシャドウ
(質量%)
サザンカの葉の抽出物 0.01
エタノール 5.0
酸化防止剤 適量
流動パラフィン 6.0
メチルポリシロキサン 2.0
香料 適量
セスキオレイン酸ソルビタン 2.0
タルク 45.0
マイカ 15.0
セリサイト 5.0
顔料 14.5
パール顔料 10.0
<Prescription Example 6> Eyeshadow (mass%)
Sasanqua leaf extract 0.01
Ethanol 5.0
Antioxidant appropriate amount liquid paraffin 6.0
Methylpolysiloxane 2.0
Perfume appropriate amount sorbitan sesquioleate 2.0
Talc 45.0
Mica 15.0
Sericite 5.0
Pigment 14.5
Pearl pigment 10.0
上記した処方例1〜6にて作成した化粧料を各化粧料について健常女性パネラー20名(計120名)に2週間使用してもらい使用感触及び皮膚刺激について確認した。その結果、1名の皮膚刺激も見られず使用感触も十分に満足する回答を得た。 The cosmetics prepared in the above-mentioned prescription examples 1 to 6 were used by 20 healthy female panelists (120 persons in total) for each cosmetic for 2 weeks, and the use feeling and skin irritation were confirmed. As a result, no skin irritation was seen by one person, and an answer that fully satisfied the feeling of use was obtained.
本発明によれば、サザンカの葉の抽出物を含むことを特徴とする抗菌剤を配合する化粧料が提供され、該化粧料は、パラオキシ安息香酸エステルを使用せずして、十分な抗菌作用を有することによって安全性に優れたものである。 According to the present invention, there is provided a cosmetic comprising an antibacterial agent characterized by containing an extract of sasanqua leaves, and the cosmetic has sufficient antibacterial activity without using a paraoxybenzoic acid ester. By having, it is excellent in safety.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006096017A JP4791873B2 (en) | 2006-03-30 | 2006-03-30 | Antibacterial agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006096017A JP4791873B2 (en) | 2006-03-30 | 2006-03-30 | Antibacterial agent |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2007269667A true JP2007269667A (en) | 2007-10-18 |
JP4791873B2 JP4791873B2 (en) | 2011-10-12 |
Family
ID=38672830
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006096017A Active JP4791873B2 (en) | 2006-03-30 | 2006-03-30 | Antibacterial agent |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4791873B2 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6041473A (en) * | 1983-08-15 | 1985-03-05 | Shiraimatsu Shinyaku Kk | Antimicrobial agent |
JPH02276562A (en) * | 1989-04-19 | 1990-11-13 | Mitsui Norin Kk | Antimicrobial agent |
JPH07309770A (en) * | 1994-05-20 | 1995-11-28 | Narisu Keshohin:Kk | Mucopolysaccharides fractionation inhibitor, active oxygen eliminator and cosmetic |
JP2000212093A (en) * | 1998-11-17 | 2000-08-02 | Ito En Ltd | Antifungal agent |
JP2003342190A (en) * | 2002-03-19 | 2003-12-03 | Fancl Corp | Anti-helicobacter pylori composition |
WO2007108042A1 (en) * | 2006-03-15 | 2007-09-27 | Tropical Technology Center Ltd. | Antiinflammatory agent |
-
2006
- 2006-03-30 JP JP2006096017A patent/JP4791873B2/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6041473A (en) * | 1983-08-15 | 1985-03-05 | Shiraimatsu Shinyaku Kk | Antimicrobial agent |
JPH02276562A (en) * | 1989-04-19 | 1990-11-13 | Mitsui Norin Kk | Antimicrobial agent |
JPH07309770A (en) * | 1994-05-20 | 1995-11-28 | Narisu Keshohin:Kk | Mucopolysaccharides fractionation inhibitor, active oxygen eliminator and cosmetic |
JP2000212093A (en) * | 1998-11-17 | 2000-08-02 | Ito En Ltd | Antifungal agent |
JP2003342190A (en) * | 2002-03-19 | 2003-12-03 | Fancl Corp | Anti-helicobacter pylori composition |
WO2007108042A1 (en) * | 2006-03-15 | 2007-09-27 | Tropical Technology Center Ltd. | Antiinflammatory agent |
Also Published As
Publication number | Publication date |
---|---|
JP4791873B2 (en) | 2011-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4880816B2 (en) | Skin anti-aging agent | |
JP2000095663A (en) | Agent for external use containing plant extract | |
KR102142311B1 (en) | Skin external composition comprising tangeretin | |
JP2003128512A (en) | Antibacterial composition for cosmetic | |
JP2004043336A (en) | Antimicrobial agent and cosmetic incorporated with the same | |
JP2011026216A (en) | Cosmetic | |
JP2001335457A (en) | Antioxidant and skin care preparation containing the same | |
JP2003113040A (en) | Antibacterial cosmetic composition | |
JP2006151831A (en) | Antioxidant, dna damage inhibitor or skin care preparation | |
JP4294640B2 (en) | Antiseptic disinfectant, cosmetics or pharmaceuticals containing the antiseptic disinfectant, and antiseptic disinfection method | |
JP2005232125A (en) | Antiseptic sterilizer, and cosmetic, medicine and food each compounded with the antiseptic sterilizer | |
KR20150137692A (en) | Cosmetic composition comtaining Lethariella cladonioides extracts | |
KR20160008942A (en) | A composition comprising fermented Myrothamnus flabellifolius extract and the use thereof | |
JP4791873B2 (en) | Antibacterial agent | |
CA3181110A1 (en) | An antimicrobial composition for tackling malodour | |
JP2002128632A (en) | Cosmetic | |
JP5972732B2 (en) | Antibacterial agent and external preparation for skin | |
Sharma et al. | The Art and Science of Cosmetics: Understanding the Ingredients | |
JP2004300143A (en) | Antiseptic bactericidal agent, and the agent-compounded cosmetic, pharmaceutical and foodstuff | |
JP2002128654A (en) | Skin care preparation | |
KR20160000318A (en) | Cosmetic composition containing Fir tree oil | |
JP6253702B2 (en) | Cosmetics for external use with Connals louver extract | |
JP2007137768A (en) | Skin or hair cosmetic | |
JP4773670B2 (en) | Elastin-like agent and cosmetics containing the same | |
JP6060022B2 (en) | Topical skin preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090327 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20110328 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110412 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110609 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110712 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110722 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140729 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4791873 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |